SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Loxo Oncology, Inc. (LOXO)

LOXO RSS Feed
Add LOXO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/6/2017 5:45:12 AM - Followers: 0 - Board type: Free - Posts Today: 0

Loxo Oncology, Inc. One Landmark Square Suite 1122 Stamford, CT 06901 United States Phone: 203-653-3880 Website: http://www.loxooncology.com Loxo Oncology, Inc. engages in the discovery, development, and commercialization of cancer therapies in the United States. Its lead product candidate includes LOXO-101, an oral and selective inhibitor of tropomyosin receptor kinase (TRK), which is in a Phase I dose escalation trial for the treatment of patients with tumor types, such as lung, head and neck, melanoma, colorectal, sarcoma, and breast cancer. The company’s preclinical programs include RET inhibitor that optimizes potency for RET fusion proteins, mutations, and clinically-identified resistance mutations; FGFR inhibitor that optimizes on potency against receptors comprising four isoforms with tyrosine kinase domains; and FLT3 inhibitor that optimizes on potency for the FLT3 internal tandem duplication mutations. It has a drug discovery collaboration agreement with Array BioPharma, Inc. to obtain various rights to TRK inhibitor program and oncology targets. The company was founded in 2013 and is headquartered in Stamford, Connecticut.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
LOXO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
LOXO News: Current Report Filing (8-k) 03/21/2017 08:01:07 AM
LOXO News: Loxo Oncology Announces Larotrectinib Pan-TRK IHC Companion Diagnostic Collaboration with Ventana Medical Systems, Inc., a me... 03/20/2017 06:45:00 AM
LOXO News: Statement of Changes in Beneficial Ownership (4) 03/17/2017 05:16:10 PM
LOXO News: Statement of Changes in Beneficial Ownership (4) 03/17/2017 05:14:26 PM
LOXO News: Statement of Changes in Beneficial Ownership (4) 03/17/2017 05:12:15 PM
PostSubject
#5   Loxo Oncology (LOXO +5.28%) fell over 3% in jones99 01/06/17 05:45:12 AM
#4   $LOXO *DJ Loxo Oncology Announces EMA Orphan Drug jones99 01/15/16 06:53:46 AM
#3   Eyeing this oncology stock as my top biotech edge 01/02/16 03:50:24 PM
#2   " agraff04 06/15/15 03:13:43 PM
#1   $LOXO recent news/filings stocktrademan 06/13/15 09:58:05 PM
PostSubject